Target intelligence / Profile preview

RNA, 7SK small nuclear pseudogene 125 (RN7SKP125)

Target
RN7SKP125
Molecular classification
Other, pseudogene, noncoding RNA pseudogene
01

Overview

RN7SK pseudogene 125 (RN7SKP125) is classified as a pseudogene related to the 7SK small nuclear RNA, which itself is a regulatory noncoding RNA involved in transcription control through modulation of the elongation factor P-TEFb and as an RNA scaffold recruiting numerous RNA-binding proteins important for neuronal differentiation, gene regulation, mRNA metabolism, and ribosome biogenesis. However, as a pseudogene, RN7SKP125 is not expected to encode a functional molecule, nor is it established as a therapeutic or biological target, and there is no evidence of its direct biological function, disease association, drug interaction, biomarker role, or safety profile in the literature. 7SK snRNA is a master regulator of transcriptional elongation, especially important in neurons, serving as a scaffold for complexes that regulate gene expression, mRNA processing, and ribosome biogenesis. RN7SK pseudogenes are genomic sequences resembling the functional 7SK snRNA gene but do not produce functional RNA. Pseudogenes typically arise from gene duplication or retrotransposition events and are usually nonfunctional, though rarely they may have regulatory roles (not documented for RN7SKP125). Therapeutic relevance: Pseudogenes such as RN7SKP125 are not considered drug targets, receptors, enzymes, or similar entities, and are not cited in current research as having any functional role, therapeutic relevance, or disease mechanism. The information provided here is distinct from functional 7SK snRNA, which itself is a key noncoding RNA for transcriptional regulation, but RN7SKP125 refers specifically to a pseudogene variant, not the active molecule. If your interest lies in the functional 7SK snRNA, the descriptions above describe its role as a transcriptional regulator and scaffold for large RNA-protein complexes central to neuronal differentiation and homeostasis, but RN7SKP125 itself does not map to any known functional molecule or therapeutic target.

Other names
RN7SKP125RNA, 7SK small nuclear pseudogene 125

Beyond the preview

Go deeper on RNA, 7SK small nuclear pseudogene 125 (RN7SKP125).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 125 (RN7SKP125).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call